Page last updated: 2024-11-06

prednisolone and Pneumonia, Viral

prednisolone has been researched along with Pneumonia, Viral in 38 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.

Research Excerpts

ExcerptRelevanceReference
" With only few case studies published on SARS-CoV-2 infection in patients with rheumatic diseases, we report a 25-year-old male who developed moderate coronavirus disease 2019 (COVID-19) with fever, mild dyspnea, and no major complications despite having received high-dose prednisolone, cyclophosphamide, and rituximab for the treatment of highly active, life-threatening eosinophilic granulomatosis with polyangiitis (EGPA)."3.96COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis. ( Craig-Mueller, N; Hengel, H; Huzly, D; Kern, WV; Panning, M; Schramm, MA; Thiel, J; Venhoff, N; Voll, RE; Wagner, D, 2020)
" A 40-year-old man with a history of rheumatoid arthritis treated with prednisolone, Disease-Modifying Anti-Rheumatic Drugs (DMARDs), and biologic agents was admitted with chief complaints of fever, chills, malaise, myalgia, and dyspnea."3.96COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with? ( Ahmadinejad, Z; Assari, R; Ayoobi Yazdi, N; Javanshayani, P; Khalili Afousi, H; Mazloomi, SH; Ziaee, V, 2020)
"Severe H1N1 pneumonia with acute respiratory failure results in infiltration of lungs due to the presence of hyperactive immune cells."2.79Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure. ( Chou, CL; Chung, FT; Huang, SY; Kuo, HP; Lee, KY; Lin, SM; Lin, TY; Wang, CH, 2014)
"A 61-year old patient with ankylosing spondylitis who was on secukinumab therapy for 5 months admitted with newly onset fever and gastrointestinal complaints."2.66Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review. ( Coskun Benlidayi, I; Guzel, R; Kurtaran, B; Tirasci, E, 2020)
"Because of severe hypoxemia, the patient required mechanical ventilation and additional oxygenation by an intravascular oxygenator."2.39Severe respiratory insufficiency complicating Epstein-Barr virus infection: case report and review. ( Baumann, PC; Haller, A; Krause, M; von Segesser, L, 1995)
"Prednisolone was tapered to 15 mg when current COVID-19 was suspected, considering his recent cough, dyspnea, and fever."1.56Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report. ( Daneshpazhooh, M; Isazade, A; Noormohammadpour, P; Soori, T, 2020)
" We also comment on suggested dosing for patients who usually take modified release hydrocortisone or prednisolone."1.56ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency. ( Arlt, W; Baldeweg, SE; Pearce, SHS; Simpson, HL, 2020)
"Health-care providers worldwide in the coronavirus disease 2019 pandemic have been confronted with an unprecedented number of viral lung infections, with great variance in symptoms and severity."1.56Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019. ( Beyer, M; Fogarassy, P; Hellmich, B; Löffler, C; Mahrhold, J, 2020)
" For the treatment of COVID-19 pneumonia, systemic and in-depth investigation is needed to determine the timing and dosage of glucocorticoids needed to inhibit overwhelming inflammatory response and not the protective immune response to COVID-19 pneumonia."1.56Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience. ( Hu, Y; Hu, Z; Li, L; Peng, P; Wang, T; Wang, X; Zhang, Z, 2020)
"They also presented with pulmonary fibrosis findings, including traction bronchiectasis and marked lung volume reduction."1.56Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports. ( Akiyama, Y; Fukunaga, K; Hasegawa, N; Ishii, M; Kabata, H; Kaneko, Y; Kondo, Y; Lee, H; Okamori, S, 2020)
"He had depression and Alzheimer's disease as complications."1.34[An autopsy case of microscopic polyangiitis complicated with pulmonary aspergilloma and cytomegalovirus pneumonia]. ( Kimura, K; Konno, Y; Kuboshima, S; Miura, H; Okabayashi, J; Sakurada, T; Sasaki, H; Sato, T; Shima, Y; Shirai, S; Tsuruoka, K; Yasuda, T, 2007)
" Although corticosteroid therapy has been reported to be effective in some CCE patients, the indications of steroid therapy, dosage of corticosteroids, duration of the treatment, or efficacy of prophylactic administration of antibiotics are not yet established."1.33[Pulmonary infection of Pneumocystis carinii and Cytomegalo virus in the treatment of cholesterol crystal embolism]. ( Fujii, M; Fujita, Y; Kitamura, H; Matsui, I; Okuno, A; Yamamoto, R, 2006)
"The treatment with prednisolone and cyclophosphamide reduced his symptoms and laboratory data including serum C-ANCA."1.31[A case of Wegener's granulomatosis complicated with cytomegalovirus pneumonia during the treatment with immunosuppressants]. ( Izaki, K; Kawano, T; Kohno, S; Kondo, Y; Machida, I; Matsuse, H; Shimoda, T; Tomari, SY, 2002)
"She developed hypoxemia after intensive immunosuppressive therapy with prednisolone and cyclophosphamide."1.29Cytomegalovirus-induced interstitial pneumonitis in a patient with systemic lupus erythematosus. ( Asayama, R; Shibuya, T; Takenaka, K; Tokunaga, Y, 1996)
"Children with malignancy have a high incidence of pneumonia and pneumonitis and death is rare if the patient does not have terminal malignant disease."1.28Pneumonia and pneumonitis in childhood malignancy. ( Eden, OB; Elton, R; Shaw, NJ, 1992)

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19903 (7.89)18.7374
1990's5 (13.16)18.2507
2000's7 (18.42)29.6817
2010's4 (10.53)24.3611
2020's19 (50.00)2.80

Authors

AuthorsStudies
Daneshpazhooh, M1
Soori, T1
Isazade, A1
Noormohammadpour, P1
Arlt, W1
Baldeweg, SE1
Pearce, SHS1
Simpson, HL1
Grinspan, ZM1
Mytinger, JR1
Baumer, FM1
Ciliberto, MA1
Cohen, BH1
Dlugos, DJ1
Harini, C1
Hussain, SA1
Joshi, SM1
Keator, CG1
Knupp, KG1
McGoldrick, PE1
Nickels, KC1
Park, JT1
Pasupuleti, A1
Patel, AD1
Pomeroy, SL1
Shahid, AM1
Shellhaas, RA1
Shrey, DW1
Singh, RK1
Wolf, SM1
Yozawitz, EG1
Yuskaitis, CJ1
Waugh, JL1
Pearl, PL1
Coleman, H1
Snell, LB1
Simons, R1
Douthwaite, ST1
Lee, MJ1
Asfuroglu Kalkan, E1
Ates, I1
Vahedi, E1
Ghanei, M1
Ghazvini, A1
Azadi, H1
Izadi, M1
Panahi, Y1
Fathi, S1
Salesi, M1
Saadat, SH1
Ghazale, AH1
Rezapour, M1
Mozafari, A1
Zand, N1
Parsaei, MR1
Ranjkesh, MH1
Jafari, R1
Movaseghi, F1
Darabi, E1
Coskun Benlidayi, I1
Kurtaran, B1
Tirasci, E1
Guzel, R1
Löffler, C1
Mahrhold, J1
Fogarassy, P1
Beyer, M1
Hellmich, B1
Dahl Mathiasen, V1
Jensen-Fangel, S1
Skov, K1
Leth, S1
Kuzeva, A1
Dost, S1
Lams, B1
Agarwal, S1
Furmedge, DS1
Hu, Y1
Wang, T1
Hu, Z1
Wang, X1
Zhang, Z1
Li, L1
Peng, P1
Mattar, SAM1
Koh, SJQ1
Rama Chandran, S1
Cherng, BPZ1
Okamori, S1
Lee, H1
Kondo, Y2
Akiyama, Y1
Kabata, H1
Kaneko, Y1
Ishii, M1
Hasegawa, N1
Fukunaga, K1
Schramm, MA1
Venhoff, N1
Wagner, D1
Thiel, J1
Huzly, D1
Craig-Mueller, N1
Panning, M1
Hengel, H1
Kern, WV1
Voll, RE1
Nofal, A1
Fawzy, MM1
Sharaf El Deen, SM1
El-Hawary, EE1
Koumpa, FS1
Forde, CT1
Manjaly, JG1
Tzukert, K1
Abel, R1
Mor Yosef Levi, I1
Gork, I1
Yosha Orpaz, L1
Azmanov, H1
Dranitzki Elhalel, M1
Ahmadinejad, Z1
Assari, R1
Ayoobi Yazdi, N1
Mazloomi, SH1
Javanshayani, P1
Khalili Afousi, H1
Ziaee, V1
Singh, G1
Mathur, U1
Wang, CH1
Chung, FT1
Lin, SM1
Huang, SY1
Chou, CL1
Lee, KY1
Lin, TY1
Kuo, HP1
Ison, MG1
Chuang, YC1
Ruan, SY1
Huang, CT1
Suter, C1
Buergi, U1
Eigenmann, K1
Franzen, D1
Matsuse, H1
Machida, I1
Kawano, T1
Tomari, SY1
Izaki, K1
Shimoda, T1
Kohno, S1
THOMPSON, CA1
CANTRELL, FP1
Kaşifoğlu, T1
Korkmaz, C1
Ozkan, R1
Okuno, A1
Yamamoto, R1
Matsui, I1
Kitamura, H1
Fujita, Y1
Fujii, M1
Chikuie, N1
Ikeda, S1
Wakura, D1
Fujisaka, Y1
Fujita, K1
Takasu, T1
Goto, I1
Hanafusa, T1
Kuboshima, S1
Tsuruoka, K1
Shirai, S1
Sasaki, H1
Sakurada, T1
Miura, H1
Okabayashi, J1
Konno, Y1
Shima, Y1
Yasuda, T1
Sato, T1
Kimura, K1
Haller, A1
von Segesser, L1
Baumann, PC1
Krause, M1
Tokunaga, Y1
Takenaka, K1
Asayama, R1
Shibuya, T1
Grigg, A1
Chapman, R1
Szer, J1
Nagasawa, T1
Sakuma, H1
Araki, S1
Watanabe, A1
Makino, M1
Nonaka, I1
Ide, S1
Koga, T1
Rikimaru, T1
Katsuki, Y1
Oizumi, K1
Shaw, NJ1
Elton, R1
Eden, OB1
Clerc, D1
Brousse, C1
Mariette, X1
Bennet, P1
Bisson, M1
Harper, JR1
Marshall, RD1
Parkinson, MS1
Zabolay, S1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Thyroid Function Tests and the Status of Thyroid Autoantibodies in Hospitalized Covid-19 Patients and Their Relationship With White Blood Cells, Neutrophil / Lymphocyte Ratio, c Reactive Protein, Fibrinogen, Procalcitonin, Ferritin and D-dimer[NCT04659200]20 participants (Actual)Observational2020-09-01Completed
Efficacy and Safety of Sirolimus for Treating COVID-19 Infection[NCT04461340]Phase 240 participants (Anticipated)Interventional2020-08-15Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for prednisolone and Pneumonia, Viral

ArticleYear
Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.
    Rheumatology international, 2020, Volume: 40, Issue:10

    Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antirheumatic Agents; Betacoronavirus; Coronaviru

2020
Severe respiratory insufficiency complicating Epstein-Barr virus infection: case report and review.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:1

    Topics: Acute Disease; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Extracorporeal Membrane Oxyg

1995

Trials

1 trial available for prednisolone and Pneumonia, Viral

ArticleYear
Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure.
    Critical care medicine, 2014, Volume: 42, Issue:2

    Topics: Acute Disease; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Glucocorticoids; Humans; I

2014

Other Studies

35 other studies available for prednisolone and Pneumonia, Viral

ArticleYear
Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report.
    The Journal of dermatological treatment, 2020, Volume: 31, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; C

2020
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency.
    European journal of endocrinology, 2020, Volume: 183, Issue:1

    Topics: Acute Disease; Adrenal Insufficiency; Adult; Betacoronavirus; Child; Child, Preschool; Coronavirus I

2020
Crisis Standard of Care: Management of Infantile Spasms during COVID-19.
    Annals of neurology, 2020, Volume: 88, Issue:2

    Topics: Adrenocorticotropic Hormone; Anticonvulsants; Betacoronavirus; Coronavirus Infections; COVID-19; Del

2020
Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV.
    AIDS (London, England), 2020, 07-01, Volume: 34, Issue:8

    Topics: Anti-Bacterial Agents; Anti-HIV Agents; Asthma; Betacoronavirus; Clinical Laboratory Techniques; Cor

2020
A case of subacute thyroiditis associated with Covid-19 infection.
    Journal of endocrinological investigation, 2020, Volume: 43, Issue:8

    Topics: Adult; Anti-Inflammatory Agents; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; C

2020
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
    Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2020, Volume: 28, Issue:2

    Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combi

2020
Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.
    Chest, 2020, Volume: 158, Issue:5

    Topics: Aged; Aortitis; Autoimmune Diseases; Betacoronavirus; Carcinoma, Transitional Cell; Chemoradiotherap

2020
Uneventful case of COVID-19 in a kidney transplant recipient.
    BMJ case reports, 2020, Jul-20, Volume: 13, Issue:7

    Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Female; Glucocorticoids; Hospitalization; Humans;

2020
Time-critical administration of corticosteroid rescue therapy for COVID-19 pneumonitis in a ward-based patient with chronic obstructive pulmonary disease.
    British journal of hospital medicine (London, England : 2005), 2020, 07-02, Volume: 81, Issue:7

    Topics: Aged; Betacoronavirus; C-Reactive Protein; Clinical Deterioration; Coronavirus Infections; COVID-19;

2020
Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 130

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Betacoronavirus; Clinical Laboratory Techniques; Coinfec

2020
Subacute thyroiditis associated with COVID-19.
    BMJ case reports, 2020, Aug-25, Volume: 13, Issue:8

    Topics: Adult; Betacoronavirus; Coronavirus Infections; COVID-19; Diagnosis, Differential; Glucocorticoids;

2020
Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports.
    Medicine, 2020, Aug-28, Volume: 99, Issue:35

    Topics: Antiviral Agents; Coronavirus Infections; COVID-19; Disease Progression; Dose-Response Relationship,

2020
COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Adult; Antiviral Agents; Betacoronavirus; Churg-Strauss Syndrome; Coronavirus Infections; COVID-19;

2020
Herpes zoster ophthalmicus in COVID-19 patients.
    International journal of dermatology, 2020, Volume: 59, Issue:12

    Topics: Acyclovir; Administration, Cutaneous; Administration, Oral; Adult; Antiviral Agents; Betacoronavirus

2020
Sudden irreversible hearing loss post COVID-19.
    BMJ case reports, 2020, Oct-13, Volume: 13, Issue:11

    Topics: Administration, Oral; Betacoronavirus; Coronavirus Infections; COVID-19; Glucocorticoids; Hearing Lo

2020
The Challenge of Treating Kidney Transplant Recipients Infected with COVID-19: Report of the First Cases in Israel.
    The Israel Medical Association journal : IMAJ, 2020, Volume: 22, Issue:10

    Topics: Anti-Infective Agents; Azithromycin; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus In

2020
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?
    Reumatismo, 2020, Nov-19, Volume: 72, Issue:3

    Topics: Adalimumab; Adult; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Azathioprine; Beta

2020
Acute graft rejection in a COVID-19 patient: Co-incidence or causal association?
    Indian journal of ophthalmology, 2021, Volume: 69, Issue:4

    Topics: Acute Disease; Adult; Cataract Extraction; Corneal Diseases; COVID-19; COVID-19 Drug Treatment; COVI

2021
Adjuvant immunosuppression in the management of severe influenza: friend or foe?
    Critical care medicine, 2014, Volume: 42, Issue:2

    Topics: Female; Glucocorticoids; Humans; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Influenz

2014
Compelling results of adjuvant therapy with sirolimus for severe H1N1 pneumonia.
    Critical care medicine, 2014, Volume: 42, Issue:10

    Topics: Female; Glucocorticoids; Humans; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Influenz

2014
Severe acute measles pneumonitis: virus isolation in bronchoalveolar lavage fluid.
    BMJ case reports, 2015, Oct-27, Volume: 2015

    Topics: Adult; Bronchiolitis Obliterans; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Glucocortico

2015
[A case of Wegener's granulomatosis complicated with cytomegalovirus pneumonia during the treatment with immunosuppressants].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2002, Volume: 40, Issue:7

    Topics: Antiviral Agents; Cyclophosphamide; Cytomegalovirus Infections; Drug Therapy, Combination; Ganciclov

2002
Chickenpox pneumonia treated with prednisolone: a case report.
    Annals of internal medicine, 1958, Volume: 49, Issue:5

    Topics: Chickenpox; Humans; Pneumonia; Pneumonia, Viral; Prednisolone

1958
Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis.
    Clinical rheumatology, 2006, Volume: 25, Issue:5

    Topics: Adult; Antiviral Agents; Azathioprine; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; De

2006
[Pulmonary infection of Pneumocystis carinii and Cytomegalo virus in the treatment of cholesterol crystal embolism].
    Nihon Jinzo Gakkai shi, 2006, Volume: 48, Issue:5

    Topics: Angioplasty, Balloon, Coronary; Cytomegalovirus Infections; Embolism, Cholesterol; Humans; Male; Mid

2006
[A case of bullous pemphigoid associated with Pneumocystis pneumonia and Cytomegalovirus pneumonia].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2006, Volume: 44, Issue:12

    Topics: Aged; Anti-Inflammatory Agents; Cytomegalovirus Infections; Humans; Male; Pemphigoid, Bullous; Pneum

2006
[An autopsy case of microscopic polyangiitis complicated with pulmonary aspergilloma and cytomegalovirus pneumonia].
    Nihon Jinzo Gakkai shi, 2007, Volume: 49, Issue:2

    Topics: Aged; Alzheimer Disease; Antibodies, Antineutrophil Cytoplasmic; Aspergillosis; Cytomegalovirus Infe

2007
Cytomegalovirus-induced interstitial pneumonitis in a patient with systemic lupus erythematosus.
    Internal medicine (Tokyo, Japan), 1996, Volume: 35, Issue:6

    Topics: Antigens, Viral; Antiviral Agents; Cyclophosphamide; Cytomegalovirus; Cytomegalovirus Infections; Fe

1996
Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine.
    Bone marrow transplantation, 1998, Volume: 21, Issue:6

    Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; C

1998
[A patient of infantile polymyositis triggered by respiratory syncytium virus infection].
    No to hattatsu = Brain and development, 2000, Volume: 32, Issue:6

    Topics: Acute Disease; Humans; Infant; Male; Methylprednisolone; Pneumonia, Viral; Polymyositis; Prednisolon

2000
Good's syndrome presenting with cytomegalovirus pneumonia.
    Internal medicine (Tokyo, Japan), 2000, Volume: 39, Issue:12

    Topics: Agammaglobulinemia; Antibody Formation; B-Lymphocytes; Cytomegalovirus Infections; Disease Susceptib

2000
Pneumonia and pneumonitis in childhood malignancy.
    Acta paediatrica (Oslo, Norway : 1992), 1992, Volume: 81, Issue:3

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; C

1992
Cytomegalovirus pneumonia in a patient with rheumatoid arthritis treated with low dose methotrexate and prednisone.
    Annals of the rheumatic diseases, 1991, Volume: 50, Issue:1

    Topics: Arthritis, Rheumatoid; Cytomegalovirus Infections; Humans; Male; Methotrexate; Middle Aged; Opportun

1991
Intermittent positive-pressure ventilation in chicken-pox pneumonitis.
    British medical journal, 1969, Sep-13, Volume: 3, Issue:5671

    Topics: Adult; Chickenpox; Eczema; Female; Humans; Methotrexate; Pneumonia, Viral; Positive-Pressure Respira

1969
[On the therapy of fibrosis of the lung].
    Zeitschrift fur Tuberkulose und Erkrankungen der Thoraxorgane, 1968, Volume: 127, Issue:5

    Topics: Anti-Bacterial Agents; Antitubercular Agents; Glucocorticoids; Humans; Pneumoconiosis; Pneumonia, Vi

1968